SARS-CoV-2 Infection in Ivory Coast: A Serosurveillance Survey among Gold Mine Workers

ABSTRACT Of the 107 million COVID-19 cases worldwide, less than 2 million have been reported in African countries. The aim of this study was to evaluate the seroprevalence of SARS-CoV-2 infection in Ivory Coast mine workers. From July 15 to October 13, 2020, a voluntary serological test campaign was conducted in 3 sites: two gold mines, and the headquarters in Abidjan. Rapid tests to detect IgG and IgM on capillary blood were performed. To identify independent sociodemographic characteristics associated with a higher SARS-CoV-2 seroprevalence rate, a multivariate logistic regression analysis was performed. A total of 1,687 subjects were tested; 91% were male (n = 1,536), and the mean age was 37 years. The overall seroprevalence was 25.1% (n = 422), ranging between 13.6% (11.2–16.1%), 34.4% (31.1–37.7%), and 34.7% (26.2–43.2%) in mine A, in mine B, and in Abidjan, respectively. Among the 422 seropositive subjects, 74 reported mild symptoms in the three previous months and one was hospitalized for severe COVID-19 infection. SARS-CoV-2 seroprevalence is high in both gold miners and administrative staff working in Ivory Coast. The burden of infection in West Africa has probably been underestimated till now.

[1]  H. Mouquet,et al.  Sex differences in the decline of neutralizing antibodies to SARS-CoV-2 , 2020, medRxiv.

[2]  A. Amoo,et al.  SARS-CoV-2 Seropositivity in Asymptomatic Frontline Health Workers in Ibadan, Nigeria , 2020, The American journal of tropical medicine and hygiene.

[3]  M. Lipsitch,et al.  Cross-reactive memory T cells and herd immunity to SARS-CoV-2 , 2020, Nature Reviews Immunology.

[4]  G. Pialoux,et al.  Evaluation of performance of two SARS-CoV-2 Rapid IgM-IgG combined antibody tests on capillary whole blood samples from the fingertip , 2020, PLoS ONE.

[5]  D. Ekouevi,et al.  Prevalence of SARS-CoV-2 among high-risk populations in Lomé (Togo) in 2020 , 2020, medRxiv.

[6]  M. Aliyu-Paiko,et al.  Seroprevalence of COVID-19 in Niger State , 2020, medRxiv.

[7]  E. Adams,et al.  High SARS-CoV-2 seroprevalence in health care workers but relatively low numbers of deaths in urban Malawi , 2020, medRxiv.

[8]  J. Scott,et al.  Seroprevalence of anti–SARS-CoV-2 IgG antibodies in Kenyan blood donors , 2020, Science.

[9]  Andrew E Ekpenyong,et al.  Prevalence of IgG and IgM antibodies to SARS-CoV-2 among clinic staff and patients , 2020, medRxiv.

[10]  B. Gunn,et al.  Why is There Low Morbidity and Mortality of COVID-19 in Africa? , 2020, The American journal of tropical medicine and hygiene.

[11]  Charlotte L. R. Payne,et al.  COVID-19 in Africa , 2020, Nature Human Behaviour.

[12]  C. E. WHO Coronavirus Disease (COVID-19) Dashboard , 2020 .